Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
05/2005
05/26/2005CA2530605A1 Pro104 antibody compositions and methods of use
05/26/2005CA2527904A1 Lactoferrin as an adjuvant in cancer vaccines
05/25/2005EP1533619A2 Specific markers for metabolic syndrome
05/25/2005EP1533617A1 Angiogenesis inhibiting molecules, their selection, production and their use in the treatment and diagnosis of cancer
05/25/2005EP1533380A2 Recombinant protein production in a human cell comprising at least one E1 protein of adenovirus
05/25/2005EP1533370A1 Novel atypical pneumonia-causing virus
05/25/2005EP1532983A1 Immunoglobulin preparations having increased stability
05/25/2005EP1532446A2 G-protein coupled receptor ligands and methods
05/25/2005EP1532258A1 Treatment of vascular dysfunction and alzheimer's disease
05/25/2005EP1532254A2 Helper virus-free herpesvirus amplicon particles and uses thereof
05/25/2005EP1532253A1 Streptococcus uberis protein, nucleic acid sequence encoding the same and its use in a mastitis vaccine
05/25/2005EP1532251A1 Human acid sensing ion channel 2b (hasic2b), process for producing the same, and its use
05/25/2005EP1532177A2 Immunomodulatory constructs and their uses
05/25/2005EP1532174A2 Anti-igf-i receptor antibody
05/25/2005EP1532172A2 Immunogenic composition comprising an il-13 element and t cell epitopes, and itstherapeutic use
05/25/2005EP1532169A1 Variants of the major allergen phl p 1 from timothy grass
05/25/2005EP1532168A2 Method for refolding neisserial nspa protein
05/25/2005EP1532167A2 Molecular antigen arrays using a virus like particle derived from the ap205 coat protein
05/25/2005EP1532161A2 Vectors for expression of hml-2 polypeptides
05/25/2005EP1531907A1 Use of murine genomic regions identified to be involved in tumor development for the development of anti-cancer drugs and diagnosis of cancer
05/25/2005EP1531869A2 Compositions and methods for treating cancer using maytansinoid cd44 antibody immunoconjugates and chemotherapeutic agents
05/25/2005EP1531864A2 Humanized antibodies against the venezuelan equine encephalitis virus
05/25/2005EP1531863A2 Antibody-avidin fusion proteins as cytotoxic drugs
05/25/2005EP1531861A2 Mycoplasma gallisepticum formulation
05/25/2005EP1531860A2 Peptides for chlamydophila pneumoniae vaccine and diagnosis
05/25/2005EP1531859A1 Compositions and methods for transepithelial molecular transport
05/25/2005EP1531858A2 Immunogenic composition comprising a fusion protein and a saponin adjuvant
05/25/2005EP1531843A1 Method for treating cervical cancer
05/25/2005EP1531836A2 Polypeptide cleavage process
05/25/2005EP1531825A2 Use of apoptosis inducing agents in the preparation of a medicament for the treatment of liver diseases
05/25/2005EP1531823A2 Flavin n-oxides: new anti-cancer agents and pathogen eradication agents
05/25/2005EP1531800A2 Stealth lipid nanocapsules, methods for the preparation thereof and use thereof as a carrier for active principle(s)
05/25/2005EP1531796A2 Microparticles with adsorbed polypeptide-containing molecules
05/25/2005EP1531716A2 Methods for using adamts-12, an integrin and metalloprotease with thrombospondin motifs
05/25/2005EP1287137B1 REGULATION OF HUMAN $g(a)1A?ADRENERGIC RECEPTOR-LIKE G PROTEIN-COUPLED RECEPTOR
05/25/2005EP1165615B1 MONOCLONAL ANTIBODIES AGAINST HUMAN PROTEIN Mcm3, PROCESS FOR THEIR PRODUCTION, AND THEIR USE
05/25/2005EP1163335B1 MATERIALS AND METHODS RELATING TO MODULATION OF p66 EXPRESSION
05/25/2005EP1113813B1 In-vitro method of using zot or zonulin to inhibit lymphocyte proliferation in an antigen-specific manner
05/25/2005EP1027061B1 Imine-forming polysaccharides, preparation thereof and the use thereof as adjuvants and immunostimulants
05/25/2005EP1023320B1 PEPTIDES DERIVED FROM THE env GENE OF THE FELINE IMMUNODEFICIENCY VIRUS AND THEIR APPLICATIONS
05/25/2005EP0994903B1 Methods and compositions for galactosylated glycoproteins
05/25/2005EP0907370B1 Hla-a2.1 binding peptides and their uses
05/25/2005EP0888541B1 Cryptic peptides and method for their identification
05/25/2005EP0862461B1 Methods of treating established colitis using antibodies against il-12
05/25/2005EP0813419B1 Modulators of regulatory proteins
05/25/2005EP0688227B1 Production of human papillomavirus capsid protein and virus-like particles
05/25/2005EP0479866B2 Pestivirus nucleotide sequences and polypeptides, in particular from hog cholera virus
05/25/2005CN1620500A Corona-virus-like particles comprising functionally deleted genomes
05/25/2005CN1620468A Novel anti-igf-ir antibodies and uses thereof
05/25/2005CN1620467A Secreted protein
05/25/2005CN1620466A Cystine-knot fold protein
05/25/2005CN1620311A Therapeutic agent
05/25/2005CN1620310A Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
05/25/2005CN1619312A Specific markers for metabolic syndrome
05/25/2005CN1618956A Virus strain for preventing poultry influenza and its animal infection model
05/25/2005CN1618813A Human source antibody of antithyroid agent receptor mutual action protein
05/25/2005CN1618812A Human Source antibody for anti CD20 and epithelial cell adhesion molecule
05/25/2005CN1618811A Cell surface molecule mediating cell adhesion and signal transmission
05/25/2005CN1618810A New mastocancer related protein and its specificity multiclone antibody
05/25/2005CN1618809A New mastocancer related protein and its specificity multiclone antibody
05/25/2005CN1618802A Tetramer combined with SARS antigen peptide and its preparation and use
05/25/2005CN1618466A Vaccine for treating hepatitis B, and its prepn. method
05/25/2005CN1618465A 联合疫苗组合物 Combined vaccine composition
05/25/2005CN1618464A Enhanced immunogen for inactivated vaccine for infection with Japanese ence phalitis viruses and process for producing the same
05/25/2005CN1203182C Gene engineering body for somatostatin gene engineering subunit seedling
05/25/2005CN1203180C BASB006 polynucleotide(s) and polypeptide from neisseria meningitis
05/25/2005CN1203179C DNA sequence and recombination production method of graminae allergen
05/25/2005CN1203178C Multivalent antigen-binding proteins
05/25/2005CN1202864C Use of CD40:CD154 binding interruptor to prevent counter adaptive immune responses, particularly graft rejection
05/25/2005CN1202863C Antigen delivery system comprising monoglyceride or diglyceride derivatives as adjuvant
05/25/2005CN1202860C Anti-SARS virus transfer factor preparation method
05/25/2005CA2448831A1 Multi-stage cascade boosting vaccine
05/24/2005US6897294 Inhibitors of vascular endothelial growth factor activity, their uses and processes for their production
05/24/2005US6897288 Mage-A12 antigenic peptides and uses thereof
05/24/2005US6897287 Ro/SSA peptide reagents for diagnosis of autoantibodies
05/24/2005US6897054 For controlling in vitro cell proliferation; genetic engineering
05/24/2005US6897044 Drugs for treatment of cancer/autoimmune disorders; apoptosis promoters
05/24/2005US6896897 For cosmetic and over-the-counter drug applications
05/24/2005US6896888 Comprises Bacillus Calmette-Guerin (BCG) formulated with keratolytic agent (salicyclic acid) for topical application
05/24/2005US6896886 Administering neurotoxins; analgesics; antisecretory agent
05/24/2005US6896885 Combined use of anti-cytokine antibodies or antagonists and anti-CD20 for treatment of B cell lymphoma
05/24/2005US6896884 Human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases
05/24/2005CA2307655C Tolerogenic fragments of natural allergens
05/24/2005CA2133316C In vitro generation of human dendritic cells and uses thereof
05/24/2005CA2123875C Hepatitis-c virus testing
05/24/2005CA2037607C Humanised antibodies
05/20/2005CA2487657A1 Specific markers for metabolic syndrome
05/19/2005WO2005045062A2 Gene expression and polymorphisms associated with lung cancer
05/19/2005WO2005044998A2 Enhanced b cell cytotoxicity of cdim binding antibody
05/19/2005WO2005044996A2 Chimeric receptors with 4-1bb stimulatory signaling domain
05/19/2005WO2005044989A2 Polynucleotides and polypeptides of anaplasma phagocytophilum and methods of using the same
05/19/2005WO2005044982A2 Monomeric recombinant mhc molecules useful for manipulation of antigen-specific t cells
05/19/2005WO2005044861A1 Polysaccharides of helicobacter pylori
05/19/2005WO2005044859A2 Cd20 antibodies with increased fc receptor binding affinity and effector function
05/19/2005WO2005044854A2 Antagonist anti-cd40 monoclonal antibodies and methods for their use
05/19/2005WO2005044844A2 Protozoan strains of reduced virulence and use thereof
05/19/2005WO2005044366A2 System and method for transdermal vaccine delivery
05/19/2005WO2005044307A2 Methods of therapy for b cell-related cancers
05/19/2005WO2005044306A2 Use of antagonist anti-cd40 antibodies for treatment of autoimmune and inflammatory diseases and organ transplant rejection
05/19/2005WO2005044302A1 Selective erbb2 inhibitor/anti-erbb antibody combinations in the treatment of cancer
1 ... 1060 1061 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 ... 1823